Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion type Assertion NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_head.
- NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion description "[The molecular understanding of this sequence has had a profound impact on our understanding of the process(s) of colonic carcinogenesis and this understanding has begun to change the clinical care of patients with colonic polyps and cancer including changes in therapy of established CRCs (anti-epidermal growth factor receptor antibody therapy is no longer offered to patients with mutant KRAS CRCs), identification of high-risk groups (diagnosis of Lynch syndrome by molecular analysis of CRCs) and the management of precursor lesions (identification of the serrated polyp pathway to CRC).]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_provenance.
- NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion evidence source_evidence_literature NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_provenance.
- NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion SIO_000772 21266962 NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_provenance.
- NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion wasDerivedFrom befree-20150227 NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_provenance.
- NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_assertion wasGeneratedBy ECO_0000203 NP370372.RAfN4dcgAR-L-1jcTIa0tzqRe6oYsnYwVN4qnTKjnYNfM130_provenance.